HOLX Stock Price - Hologic Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch

Open $36.10
Day Range 35.10 - 37.71
52 Week Range 35.10 - 46.80
Market Cap $10.96B
Shares Outstanding 276.53M
Public Float 274.36M
Beta 0.92
Rev. per Employee $511.7K
P/E Ratio 9.52
EPS $3.79
Yield n/a
Dividend n/a
Ex-Dividend Date n/a
Short Interest 10.89M 04/13/18
% of Float Shorted 3.97%
Average Volume 2.51M

5 Day	-8.35%
1 Month	-0.97%
3 Month	-14.19%
YTD	-15.61%
1 Year	-19.90%

MarketWatch
Other Dow Jones

Hologic stock price target cut to $39 from $48 at Canaccord Genuity

May. 3, 2018 at 12:57 p.m. ET
by Tomi Kilgore

Hologic downgraded to hold from buy at Canaccord Genuity

May. 3, 2018 at 12:57 p.m. ET
by Tomi Kilgore

Hologic downgraded to hold from buy at Stifel Nicolaus

Feb. 9, 2018 at 7:57 a.m. ET
by Tomi Kilgore

18 small-cap stocks that analysts expect to rise at least 50% in 2018

Dec. 20, 2017 at 7:11 a.m. ET
by Philip van Doorn

Hologic shares down 6% after lower fiscal 2018 sales forecast

Nov. 8, 2017 at 5:35 p.m. ET
by Claudia Assis

Wall Street analysts expect gains of up to 64% on their favorite health-care stocks

Oct. 16, 2017 at 2:32 p.m. ET
by Philip van Doorn

Stock-picking fund managers double down on economic growth

Mar. 29, 2017 at 3:35 a.m. ET
by Wallace Witkowski

Hologic upgraded to buy from hold at Needham

Feb. 15, 2017 at 8:30 a.m. ET
by Tomi Kilgore

Shares of Hologic, off 4.7% at $38.25, lead S&P 500 laggards in early action

Feb. 14, 2017 at 9:44 a.m. ET
by Mark DeCambre

Cynosure's stock rockets after buyout deal with Hologic

Feb. 14, 2017 at 9:29 a.m. ET
by Tomi Kilgore

Hologic started at buy with $48 stock price target at Deutsche Bank

Jan. 18, 2017 at 8:48 a.m. ET
by Tomi Kilgore

Four stock picks in an outperforming fund that has only 31 holdings

Jan. 3, 2017 at 1:22 p.m. ET
by Philip van Doorn

January could be particularly volatile for health care stocks, Goldman warns

Dec. 22, 2016 at 3:05 a.m. ET
by Ryan Vlastelica

Hologic to sell stake in blood screening unit for $1.85 bln

Dec. 14, 2016 at 4:43 p.m. ET
by Sue Chang

Opinion

11 improving health-care companies whose stocks are loved by analysts

Nov. 4, 2016 at 2:18 p.m. ET
by Philip van Doorn

Premium

Nasdaq presses uncharted territory, S&P 500 challenges the 50-day average

Oct. 10, 2016 at 11:28 a.m. ET
by Michael Ashbaugh

Breaking

Hologic gets FDA 'emergency' use OK for Zika virus test

Jun. 17, 2016 at 6:41 p.m. ET
by Wallace Witkowski

Corrected

Icahn exits Gannett, Hologic positions; adds to Xerox

May. 16, 2016 at 6:54 p.m. ET
by Wallace Witkowski

Hologic profit rises 44%; guidance raised

Apr. 27, 2016 at 6:32 p.m. ET

Hologic, Centene tick higher on S&P 500 inclusion

Mar. 24, 2016 at 5:37 p.m. ET
by Wallace Witkowski

Carl Icahn to Launch New Board Fight With Xerox

Dec. 11, 2017 at 6:25 p.m. ET
on The Wall Street Journal

Tech Investors’ Worst Fear Might Be Surging Economic Growth

May. 10, 2017 at 9:15 a.m. ET
on The Wall Street Journal

Blood Banks Step Up Efforts Against Zika Contamination

Aug. 4, 2016 at 2:00 p.m. ET
on The Wall Street Journal

FDA Grants Emergency Authorization for Hologic Zika Test

Jun. 17, 2016 at 7:42 p.m. ET
on The Wall Street Journal

Carl Icahn Continues Selling Spree

May. 16, 2016 at 5:02 p.m. ET
on The Wall Street Journal

Relational Investors Closes Out Portfolio

Feb. 15, 2016 at 11:23 p.m. ET
on The Wall Street Journal

Hologic Is Poised to Post More Gains

Nov. 28, 2015 at 1:58 a.m. ET
on Barron's

Hologic Focusing on Growth Outside U.S., CEO Says

Nov. 16, 2015 at 7:27 p.m. ET
on The Wall Street Journal

More Companies Deal With Multiple Activists

Aug. 10, 2015 at 7:08 p.m. ET
on The Wall Street Journal

Relational Investors Exits Ingersoll-Rand, Hess and Yum

Nov. 14, 2014 at 6:48 p.m. ET
on The Wall Street Journal

Activist Investors Turn CEO Headhunters

Nov. 13, 2014 at 2:39 p.m. ET
on The Wall Street Journal

For Some CEO Candidates the Interviewer Is Carl Icahn

Nov. 13, 2014 at 1:30 p.m. ET
on The Wall Street Journal

CEO Has High Hopes for At-Home Cancer Test

Oct. 21, 2014 at 5:27 p.m. ET
on The Wall Street Journal

Icahn Lieutenants Don't Go Overboard

Sep. 18, 2014 at 12:30 p.m. ET
on The Wall Street Journal

GE Gets FDA Approval for 3-D Mammogram Machine

Sep. 2, 2014 at 7:18 p.m. ET
on The Wall Street Journal

Soros Fund Management Exits Stake in Some Tech Companies

Aug. 14, 2014 at 5:21 p.m. ET
on The Wall Street Journal

Hologic Struggling to Transform

Aug. 7, 2014 at 7:57 a.m. ET
on Barron's

The New, New Trend in M&A: Spinversions

Jul. 14, 2014 at 1:18 p.m. ET
on The Wall Street Journal

Salix Pharmaceuticals: The Newest Inversion Play

Jul. 9, 2014 at 12:58 p.m. ET
on The Wall Street Journal

Siemens Submits Application to FDA for 3-D Breast Imaging System

Jun. 26, 2014 at 12:38 p.m. ET
on The Wall Street Journal

Other News
Press Releases

Barclays Thinks Hologic’s Stock is Going to Recover

Barclays analyst Jack Meehan maintained a Buy rating on Hologic (NASDAQ: HOLX) today and set ...[...]

May. 3, 2018 at 1:08 p.m. ET
on SmarterAnalyst

Leerink Downgrades Hologic After 'Lower Quality' Q2 Revenue Beat

May. 3, 2018 at 11:07 a.m. ET
on benzinga.com

Stocks Trade Lower on Thursday

May. 3, 2018 at 11:40 a.m. ET
on GuruFocus.com

CAM Group Holding A Buys Becton, Dickinson and Co, Hologic Inc, Avery Dennison Corp, Sells ...

CAM Group Holding A Buys Becton, Dickinson and Co, Hologic Inc, Avery Dennison Corp, Sells Booking Holdings Inc, Celgene Corp, HCA Healthcare Inc

May. 3, 2018 at 10:38 a.m. ET
on GuruFocus.com

Hologic's (HOLX) Q2 Earnings Meet Estimates, Revenues Top

Solid growth at Hologic's (HOLX) Breast Health and international business drives top line in Q2.

May. 3, 2018 at 9:56 a.m. ET
on Zacks.com

Deutsche Bank Keeps Their Hold Rating on Hologic

Deutsche Bank analyst Dan Leonard maintained a Hold rating on Hologic (NASDAQ: HOLX) today and ...[...]

May. 3, 2018 at 9:17 a.m. ET
on SmarterAnalyst

Top Analyst Upgrades and Downgrades: Andeavor, Discovery, Estee Lauder, Esperion Therapeutics, Hologic, Nvidia, Yum Brands and More

The top analyst upgrades, downgrades and other research calls from Thursday include Andeavor, Discovery, Estee Lauder, Esperion Therapeutics, Hologic, Nvidia and Yum Brands.

May. 3, 2018 at 8:33 a.m. ET
on 247WallSt.com

Hologic Stock Falls Over 9% on 2Q18 Results, Lower 2018 Guidance

Yesterday, after the market closed, Hologic (HOLX) released its 2Q18 earnings results for the quarter that ended on March 31.

May. 3, 2018 at 9:14 a.m. ET
on MarketRealist.com

Hologic Receives Health Canada Authorization to Market SculpSure� Laser for Non-Invasive Body Contouring (Lipolysis) of the Back, Inner and Outer Thighs, and Under the Chin

May. 3, 2018 at 8:03 a.m. ET
on CNW Group

Hologic (HOLX) Q2 2018 Results - Earnings Call Transcript

May. 2, 2018 at 8:59 p.m. ET
on Seeking Alpha

Hologic fiscal Q2 revenues up 10%; non-GAAP EPS up 6%; revenue guidance lowered; shares down 9% after hours

May. 2, 2018 at 4:16 p.m. ET
on Seeking Alpha

10-Q: HOLOGIC INC

May. 2, 2018 at 4:21 p.m. ET
on Edgar Online - (EDG = 10Q, 10K)

Notable earnings after Wednesday’s close

May. 1, 2018 at 5:35 p.m. ET
on Seeking Alpha

Needham Remains a Buy on Hologic

In a report released today, Michael Matson from Needham maintained a Buy rating on Hologic ...[...]

May. 1, 2018 at 2:04 p.m. ET
on SmarterAnalyst

Medical Product Stock Earnings on May 2: CERN, ABC & More

Given the solid prospects in the U.S. medical products industry, here we take a peek at four major Medical Product companies scheduled to report results on May 2.

May. 1, 2018 at 6:54 a.m. ET
on Zacks.com

Can Higher System Sales Drive Cerner's (CERN) Q1 Earnings?

Cerner's (CERN) Q1 earnings likely to reflect strength in System Sales and lucrative EHR prospects.

Apr. 24, 2018 at 9:44 a.m. ET
on Zacks.com

What's in Store for Cardinal Health (CAH) in Q3 Earnings?

Cardinal Health's (CAH) Pharmaceutical business likely to put up a soft performance in Q3; raised guidance buoys optimism.

Apr. 24, 2018 at 9:13 a.m. ET
on Zacks.com

Can BD Medical Drive Becton, Dickinson's (BDX) Q2 Earnings?

Becton, Dickinson (BDX) likely to gain from core BD Medical segment and strategic buyouts.

Apr. 23, 2018 at 5:04 p.m. ET
on Zacks.com

Can Hologic (HOLX) Diagnostics Growth Recur in Q2 Earnings?

A strong Panther system and an increasing utilization of Aptima women's health assays add stimulus to Global growth within Hologic's (HOLX) molecular diagnostics.

Apr. 23, 2018 at 11:56 a.m. ET
on Zacks.com

Can Core Unit Drive Pacific Biosciences' (PACB) Q1 Earnings?

Pacific Biosciences gains ground on solid Sequel Growth, while shrinking service revenues raise concern.

Apr. 19, 2018 at 5:46 p.m. ET
on Zacks.com

Global Breast Imaging Technologies Market Competitive landscape: Siemens Medical Solutions USA

May. 3, 2018 at 12:28 a.m. ET
on marketresearch.biz

Global Digital Mobile X-Ray Devices Market Competitive landscape: Hologic Inc

May. 3, 2018 at 12:28 a.m. ET
on marketresearch.biz

Hologic Announces Financial Results for Second Quarter of Fiscal 2018

May. 2, 2018 at 4:01 p.m. ET
on PR Newswire - PRF

Global Molecular Diagnostics Equipment Market Competitive landscape: Myriad Genetics

May. 2, 2018 at 3:14 a.m. ET
on marketresearch.biz

Global Fluoroscopy Equipment Market Competitive landscape: Hologic Inc., Lepu Medical Technology Co.

May. 2, 2018 at 3:14 a.m. ET
on marketresearch.biz

Global Digital Breast Tomosynthesis (DBT) Equipment Market Competitive landscape

May. 2, 2018 at 2:54 a.m. ET
on marketresearch.biz

Hologic to Webcast Presentations at Upcoming Investor Conferences

May. 1, 2018 at 4:01 p.m. ET
on PR Newswire - PRF

The global market for biopsy devices is anticipated to reach around US$ 2 Billion by 2022

Apr. 30, 2018 at 8:00 a.m. ET
on PR Newswire - PRF

Leading Women's Health Company Hologic Features Its Innovative Suite of Products at 2018 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting

Apr. 27, 2018 at 8:00 a.m. ET
on PR Newswire - PRF

Minerva Surgical Requests Immediate Retraction of Misleading Int'l Journal of Women's Health Publication that Compares NovaSure to Minerva®, Sponsored by Hologic

Apr. 26, 2018 at 7:06 p.m. ET
on PR Newswire - PRF

Developments in the Medical Imaging Market

Apr. 26, 2018 at 9:00 a.m. ET
on PR Newswire - PRF

FDA Approval of ThinPrep® Integrated Imager Expands Automated Imaging for Pap Testing to More Labs

Apr. 25, 2018 at 8:05 a.m. ET
on PR Newswire - PRF

Patent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent Involved in Delaware Infringement Case

Apr. 24, 2018 at 10:00 a.m. ET
on BusinessWire - BZX

Women's Health Company Hologic and Actor, Director Aisha Tyler Partner to Help the One in Five Women Suffering in Silence with Heavy Periods

Apr. 24, 2018 at 8:07 a.m. ET
on PR Newswire - PRF

Global Diagnostic Imaging Market Competitive landscape: Hologic, Philips Healthcare, GE Healthcare

Apr. 24, 2018 at 2:35 a.m. ET
on marketresearch.biz

Global Bone Densitometer Market Overview 2017-2026: Hologic Inc, DMS Group, CompuMed Inc

Apr. 20, 2018 at 1:41 a.m. ET
on marketresearch.biz

/C O R R E C T I O N -- Hologic, Inc./

Apr. 19, 2018 at 7:13 p.m. ET
on PR Newswire - PRF

Women Treated with Hologic's NovaSure® Endometrial Ablation System in New Study Reported Higher Amenorrhea Rates than Those Treated with Minerva

Apr. 19, 2018 at 4:42 p.m. ET
on PR Newswire - PRF

Global Molecular Diagnostics Equipment Market Overview 2017-2026: Roche Diagnostics, Hologic Inc.

Apr. 19, 2018 at 6:00 a.m. ET
on marketresearch.biz

DGAP-News: STRATEC reports significant growth in sales and earnings in 2017

Apr. 19, 2018 at 1:00 a.m. ET
on EQS Group AG

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA. (See Full Profile)

Sell
Under
Hold
Over
Buy

Number of Ratings 21 Full Ratings

Wall Street Largely Bullish on Hologic Stock in March

Apr. 3, 2018 at 2:41 p.m. ET
on MarketRealist.com

Benzinga's Top Upgrades, Downgrades For February 9, 2018

Feb. 9, 2018 at 10:17 a.m. ET
on Benzinga.com

Deutsche Bank Downgrades Hologic, Says Core Businesses Face Structural Challenges

Jan. 19, 2018 at 10:06 a.m. ET
on Benzinga.com

Name	Chg %	Market Cap
Quest Diagnostics Inc.	-0.89%	$13.77B
Abbott Laboratories	-0.07%	$101.03B
Becton Dickinson & Co.	-1.22%	$61.29B
Boston Scientific Corp.	0.70%	$40.39B
General Electric Co.	-1.27%	$123.13B

Competitor Data Provided By

Dow	23,927.51	2.53	0.01%
S&P 500	2,630.35	-5.32	-0.20%
Nasdaq	7,087.83	-13.07	-0.18%
GlobalDow	3,023.08	-9.82	-0.32%
Gold	1,314.20	8.60	0.66%
Oil	68.52	0.59	0.87%

Hologic Inc.

$ 36.07

Customize MarketWatch

No Items in Watchlist

No Saved Watchlists

Uh oh

No Recent Tickers

Hologic stock price target cut to $39 from $48 at Canaccord Genuity

Hologic downgraded to hold from buy at Canaccord Genuity

Hologic downgraded to hold from buy at Stifel Nicolaus

Hologic upgraded to buy from hold at Needham

Shares of Hologic, off 4.7% at $38.25, lead S&P 500 laggards in early action

Hologic started at buy with $48 stock price target at Deutsche Bank

Stocks

Columns

Authors

Topics

^$ 36.07